Mitie lifts FY26 profit guidance and restarts £100m buybacks – here’s what matters
Mitie’s H1 FY26 trading update is a confident one. Revenue is up by c.10% to c.£2.7bn, operating profit guidance has been raised to at least £260m for FY26, and a new £100m share buyback has been launched over the next 12 months.
The recently completed Marlowe acquisition is already shaping the story: integration “progressing well”, cost synergies of at least £30m targeted by FY28, and an initial operating profit contribution of at least £12m in FY26. Against that, net debt has stepped up with the deal, and free cash flow guidance is lower year-on-year, so there is a balancing act in play.
Key numbers at a glance
| H1 FY26 revenue | c.£2.7bn (H1 FY25: £2.4bn) |
| Revenue growth | c.10% total, incl. c.6.1% organic and c.3.9% M&A |
| Contract wins/renewals (TCV) | c.£3.0bn (H1 FY25: £3.7bn) |
| Bid pipeline | Record £31bn |
| FY26 operating profit guidance | At least £260m (FY25: £234m) |
| FY26 free cash flow guidance | At least £120m (FY25: £143m) |
| New share buyback | £100m over 12 months (cumulative since FY23: £303m) |
| Closing net debt (post-IFRS 16) | c.£475m at 30 Sep 2025 |
| Average net debt (post-IFRS 16) | c.£332m in H1 (leverage c.1.0x) |
| Marlowe acquisition | c.£350m (290p cash = £228m + 86.6m new shares) |
| Marlowe synergy target | At least £30m by FY28 |
Revenue up c.10% – healthy mix of organic growth and M&A
Mitie delivered c.6.1% organic growth, supported by net contract wins, scope increases, pricing, and higher project volumes in defence, healthcare, local government and education. That is the sort of broad-based mix you want to see, with both ongoing services and project work contributing.
M&A added c.3.9% to growth, including the first contribution from Marlowe. With the acquisition landing in early August, the bigger impact is still to come in H2 and beyond, particularly as integration actions flow through costs and cross-sell opportunities start to bite.
Order book resilience: £3.0bn TCV and a record £31bn pipeline
Contract wins, extensions and renewals reached c.£3.0bn total contract value in the half. That is down against a record H1 last year (c.£3.7bn), but the comparison included two standout public sector wins and a major private sector extension, so the step-down looks reasonable rather than worrying.
The named wins tell a story of breadth: IFM for Aviva, immigration services for the Home Office, hygiene for Landsec’s Liverpool ONE, Manchester Airport Group and Walgreens Boots Alliance, security for the Metropolitan Police Authority and Tate Gallery, engineering for Transport for London, and projects for Willmott Dixon Construction. Renewals included security for Associated British Ports, Co-operative Group and a major UK supermarket, plus IFM for GSK, JLL and Manchester Airport Group.
The standout statistic is the record £31bn pipeline of bidding opportunities. A fat pipeline is not the same as revenue, but it increases the odds of sustaining growth into FY27 under Mitie’s Strategic Plan.
Marlowe integration: cost synergies, cross-sell and systems
Marlowe is the strategic bolt-on that consolidates Mitie’s ‘Facilities Transformation’ leadership and extends it into ‘Facilities Compliance’. The deal cost c.£350m, comprising 290p in cash per share (£228m) and 1.1 Mitie shares per Marlowe share (86.6m new Mitie shares).
Targets are clear: at least £30m of cost synergies by FY28 and at least £12m operating profit contribution in FY26. The integration workstreams are exactly where you would expect value to come from: optimising field force deployment, removing duplicate head office costs, consolidating roles, rationalising properties, migrating Marlowe onto Mitie’s cyber-secure, AI-enabled systems, consolidating procurement, and in-sourcing compliance work that Mitie currently subcontracts.
My take: the operational levers are tangible and under management’s control, which reduces integration risk. The bigger opportunity is revenue acceleration via cross-selling regulatory-driven compliance services across Mitie’s 3,000-strong customer base.
Cash, debt and capital returns: a deliberate balance
Closing net debt (post-IFRS 16) rose to c.£475m at 30 September, mainly due to the £228m cash portion of the Marlowe deal (funded by a £240m short-term bridge), £66m of shareholder returns, and c.£22m of lease liabilities added with Marlowe. This was offset by c.£50m of free cash flow in H1.
Average net debt was c.£332m, equating to leverage of c.1.0x, which sits comfortably within the 0.75-1.5x target range. Management expects leverage to reduce quickly as cash flow and profitability step up post-acquisition.
Despite the higher debt, Mitie is restarting share buybacks with a £100m programme over 12 months, taking cumulative buybacks since FY23 to £303m. The progressive dividend policy remains intact at a 30-40% payout ratio, and the company will still pursue value-accretive infill M&A. In short, Mitie is signalling confidence in cash generation while keeping optionality for deals.
Guidance upgrade and near-term catalysts
Operating profit before Other items is now expected to be at least £260m for FY26, up from £234m in FY25. The upgrade is underpinned by margin actions taken in H1, recovery of inflation and National Insurance contribution increases, and early benefits from Marlowe integration.
Free cash flow guidance is at least £120m in FY26, below last year’s £143m. That is not a red flag on its own, but it does mean investors should watch cash conversion closely as integration costs and working capital flow through.
Next catalyst: interim results on Thursday, 20 November 2025. Expect more detail on Marlowe synergy delivery, project volumes, and cash dynamics.
What looks positive
- Profit guidance raised to at least £260m with clear drivers behind it.
- Broad-based revenue growth with c.6.1% organic and project strength in key sectors.
- Record £31bn pipeline to support the next leg of growth.
- Marlowe integration plan is specific, synergy-led and already underway.
- Capital returns continue via a £100m buyback and a progressive dividend.
What to keep an eye on
- Cash flow guidance is lower year-on-year – watch cash conversion and working capital.
- Integration execution risk at Marlowe, especially systems migration and property rationalisation.
- Project volumes can be lumpy – sustaining momentum into H2 will matter.
- Debt reduction path from c.£475m closing net debt to within the lower half of the target range.
Jargon buster
- Organic growth – revenue growth excluding acquisitions and disposals.
- TCV (Total Contract Value) – the estimated value of a contract over its full term, including variable and project elements.
- Leverage – average net debt divided by EBITDA over the last 12 months. Mitie targets 0.75-1.5x.
- Post-IFRS 16 net debt – includes lease liabilities under accounting standard IFRS 16.
- NIC – National Insurance contributions. Mitie highlights good recovery of cost increases arising from NIC changes.
Bottom line
This is a confident update from Mitie: guidance up, pipeline at a record, and capital returns back on the agenda. The Marlowe acquisition raises both the opportunity and the execution bar, but the integration plan is concrete and the synergy targets look achievable.
For now, the direction of travel is positive. Delivery on cash, synergy milestones and continued win rates will decide how far that momentum runs into FY27.
